Semler Scientific, Inc. finds itself in hot water as a class action lawsuit has been filed against the company, alleging securities fraud that could have significant repercussions for its shareholders. The lawsuit, which targets Semler’s actions between March 10, 2021, and April 15, 2025, claims that the company misled investors by failing to disclose a crucial investigation by the U.S. Department of Justice. This investigation pertains to potential violations of the False Claims Act, a fact that Semler allegedly kept under wraps while discussing such violations only in hypothetical terms. As a result, the company’s public statements during this period are accused of being materially false and misleading.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
For those who have invested in Semler’s stock during this timeframe, there may be an opportunity to recover losses. Investors are encouraged to visit the link provided to learn more about their rights and the potential for financial recovery. Importantly, there is no cost or obligation to participate in this legal action.
The lawsuit is spearheaded by Levi & Korsinsky LLP, a firm with a formidable reputation in securities litigation. With over two decades of experience and a track record of securing substantial settlements for shareholders, Levi & Korsinsky is well-equipped to handle this high-stakes case. Their expertise is backed by a team of over 70 professionals, and they have consistently been recognized as one of the top securities litigation firms in the United States.
If you believe you have been affected by this situation, don’t hesitate to explore your options for recovery by visiting the link provided.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171